Stroke prevention in diabetic and other high cardiovascular risk patients

被引:6
|
作者
El-Atat F. [1 ]
Rundek T. [1 ]
Sowers J.R. [1 ]
McFarlane S.I. [1 ]
机构
[1] Division of Stroke and Critical Care, Department of Neurology, Columbia University Medical Center, New York, NY 10032
关键词
Atrial Fibrillation; Valsartan; Stroke Risk; Stroke Prevention; Systolic Hypertension;
D O I
10.1007/s11892-005-0010-7
中图分类号
学科分类号
摘要
Diabetes is a major risk factor for stroke that is usually associated with risk factors such as hypertension, obesity, albuminuria, and dyslipidemia. Furthermore, atrial fibrillation and heart failure, two of the most important risk factors of stroke, are common in the diabetic population. With the rising epidemic of diabetes, the incidence of stroke is also on the rise. Implementations of effective stroke prevention strategies appear to be the most rational option to curb this growing epidemic. In this review, we examine the epidemiologic and the pathophysiologic association between stroke and diabetes, highlighting the population-based stroke preventive measures. These include hygienic and lifestyle changes, that if applied effectively could offer a great potential for stroke prevention and reduction of the cardiovascular burden in the diabetic populations. Copyright © 2005 by Current Science Inc.
引用
收藏
页码:200 / 207
页数:7
相关论文
共 50 条
  • [1] Stroke and myocardial infarction prevention with GLP1 analogues in high or very-high cardiovascular risk diabetic patients
    Cazorla-Morallon, D.
    Cordero, A.
    Pomares Varo, A.
    Torroba Balmori, G.
    Moreno Garcia, M. J.
    Martinez Rey-Ranal, E.
    Bertomeu-Gonzalez, V
    Zuazola, P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2967 - 2967
  • [2] CARDIOVASCULAR PREVENTION IN HIGH RISK PATIENTS
    Bendersky, Mario
    Baroni, Marcos
    Cruz, Mariana
    Balestrini, Carlos
    Serra, Cesar
    Sala, Jose
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2010, 39 (04): : 303 - 308
  • [3] Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases
    Abraham, Gad
    Rutten-Jacobs, Loes
    Inouye, Michael
    STROKE, 2021, 52 (09) : 2983 - 2991
  • [4] HEMORHEOLOGICAL PROFILES OF DIABETIC STROKE PATIENTS AND DIABETIC INDIVIDUALS AT HIGH-RISK FOR STROKE
    NORDT, FJ
    SEAMAN, GVF
    BEAMER, NB
    KNOX, RJ
    DEGARMO, PL
    COULL, BM
    CLINICAL HEMORHEOLOGY, 1991, 11 (3-4): : 167 - 174
  • [5] Stroke and cardiovascular events in high risk hypertensive patients
    Zhao, L.
    Fukuda, G.
    Fukuda, M.
    Fukuda, K.
    JOURNAL OF HYPERTENSION, 2008, 26 : S1 - S1
  • [7] Network Meta-Analysis of Ticagrelor for Stroke Prevention in Patients at High Risk for Cardiovascular or Cerebrovascular Events
    Balint, Alexandra
    Tornyos, Daniel
    El Abdallaoui, Oumaima El Alaoui
    Kupo, Peter
    Komocsi, Andras
    STROKE, 2021, 52 (09) : 2809 - 2816
  • [9] Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
    Gynnild, Mari Nordbo
    Hageman, Steven H. J.
    Dorresteijn, Jannick A. N.
    Spigset, Olav
    Lydersen, Stian
    Wethal, Torgeir
    Saltvedt, Ingvild
    Visseren, Frank L. J.
    Ellekjaer, Hanne
    CLINICAL EPIDEMIOLOGY, 2021, 13 : 813 - 823
  • [10] Neurohormonal biomarkers and UKPDS stroke risk in type 2 diabetic women on primary cardiovascular prevention
    Hermans, Michel P.
    Ahn, Sylvie A.
    Rousseau, Michel F.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2008, 2 (02) : 93 - 98